In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival.
about
FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypesImproving outcome and prognosis prediction in non-muscle invasive bladder cancer using a gene expression score.Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion.High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients.Urinary transcript quantitation of CK20 and IGF2 for the non-invasive bladder cancer detection.
P2860
In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
In stage pT1 non-muscle-invasi ...... edict recurrence and survival.
@en
In stage pT1 non-muscle-invasi ...... edict recurrence and survival.
@nl
type
label
In stage pT1 non-muscle-invasi ...... edict recurrence and survival.
@en
In stage pT1 non-muscle-invasi ...... edict recurrence and survival.
@nl
prefLabel
In stage pT1 non-muscle-invasi ...... edict recurrence and survival.
@en
In stage pT1 non-muscle-invasi ...... edict recurrence and survival.
@nl
P2093
P2860
P1433
P1476
In stage pT1 non-muscle-invasi ...... edict recurrence and survival.
@en
P2093
Arndt Hartmann
BRIDGE Consortium
Markus Eckstein
Maximilian Burger
Maximilian C Kriegmair
Philipp Erben
Ralph M Wirtz
Robert Stoehr
Sebastian Eidt
Stefan Denzinger
P2860
P2888
P304
P356
10.1007/S00428-017-2064-8
P577
2017-01-10T00:00:00Z